| Version 2.5.2.0 |
|
|
Abstract
Grant Number: 1RL1AG032119-01 Project Title: Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6)
PI Information: Name Title HAGERMAN, PAUL J. pjhagerman@ucdavis.edu PROFESSOR Abstract:
There is no text on file for this abstract.Public Health Relevance:
This Public Health Relevance is not available.Thesaurus Terms:
antisense nucleic acid, disease /disorder etiology, drug discovery /isolation, fragile X syndrome, pharmacogenetics
drug delivery system
clinical research, human tissue
Institution: UNIVERSITY OF CALIFORNIA DAVIS OFFICE OF RESEARCH - SPONSORED PROGRAMS DAVIS, CA 95618 Fiscal Year: 2007 Department: BIOLOGICAL CHEMISTRY Project Start: 30-SEP-2007 Project End: 30-JUN-2012 ICD: NATIONAL INSTITUTE ON AGING IRG: ZRR1